Valuation check: OCDX's profit margin is -0.02%, below the Healthcare sector average of 15.29%.
Get informed when a big investor buys or sells
+ FollowAs of Apr 2022
Trailing 12 months ending Apr 2022
The latest profit margin for OCDX is -0.02% as of April 2022. That compares with -8.03% in the prior-year period — up 99.8% year over year. That is below the Healthcare sector average of 15.29%. Investors often review this figure alongside Ortho Clinical Diagnostics Holdings plc's historical trend and sector peers before judging valuation or financial health.
Over the past year, OCDX's profit margin moved from -8.03% to -0.02% — a 99.8% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Ortho Clinical Diagnostics Holdings plc's valuation or profitability profile.
Against Healthcare companies, OCDX currently prints -0.02% for profit margin, while the sector average sits near 15.29%. That is roughly 100.1% below the sector mean. Large gaps often invite a closer look at Ortho Clinical Diagnostics Holdings plc's growth, margins, and balance sheet.
Profit Margin shows how effectively Ortho Clinical Diagnostics Holdings plc converts resources into returns. At -0.02%, OCDX may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -8.03% in the prior-year period — up 99.8% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting OCDX's profit margin (-0.02%), review year-over-year change from -8.03%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.